Get notified when JEF files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsStanding Risk Factors
- Goodwill Impairment (unchanged) — The company recorded a $65.4 million asset impairment charge in the six months ended May 31, 2026, likely related to the Tessellis business now held for sale.
Q2 revenue +35% on record advisory, equity underwriting; ~$1.47B (27.6M × $53.42; filing rounds to $1.5B) equity offering completed
Filed July 9, 2026 · Period ending May 31, 2026 · Compared to 10-Q Jul 9, 2025 · ~2 min read
Key Changes
-
high
Net revenues rose 35.0% to $2.21B in Q2 (30.9% for six months to $4.22B), driven by record advisory revenues of $674M (+47%) and equity underwriting of $371M (+203%). Net earnings attributable to common shareholders jumped 157% to $226M.
MD&A: Consolidated Results verify on EDGAR → -
high
Completed ~$1.47B (27.6M × $53.42; filing rounds to $1.5B) equity offering (27.6M shares at $53.42), representing material dilution to existing holders. Separately, repurchased $371.7M of shares under the buyback program during the six-month period.
Notes: Equity & Cash Flow Statement verify on EDGAR → -
high
Introduced 9.2M non-voting common shares via exchange of voting shares, reducing voting shares outstanding from 206.3M to 194.1M. This new capital structure element concentrates voting control among remaining voting shareholders.
Notes: Equity verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (ADMT 10-K) is open in full — no account needed.
Partner
Trade JEF commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jul 11, 2026 · How we verify